Vermillion Shareholders Seek Change in Board Members | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – A trio of Vermillion shareholders have notified the firm that they intend to nominate two people for election to the board of directors as they seek to replace Gail Page and John Hamilton.

Page is Vermillion's president and CEO, and Hamilton is a former VP and CFO of Depomed but is not an executive of the firm.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.